Clinical trial
The Influence of Gene Polymorphism on Clinical Outcomes in Patients Undergoing PCI
NCT03758248 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Influence of Gene Polymorphism on Clinical Outcomes in Patients Undergoing PCI
- Lead sponsor
- Beijing Anzhen Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 1, 2018
- Completion date
- September 30, 2021
- Enrollment
- 12,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
antiplatelet therapy, cyp2c19 polymorphism